Notice Pursuant to The National Cooperative Research and Production Act of 1993-Medical CBRN Defense Consortium, 20488-20489 [2017-08849]
Download as PDF
<![CDATA[
20488
Federal Register / Vol. 82, No. 83 / Tuesday, May 2, 2017 / Notices
T.12S., R.19E.,
Secs. 2, 4, 6, 8, and 10;
Sec. 15, S1⁄2;
Sec. 17, S1⁄2;
Secs. 18 thru 22 and 27 thru 34.
The area described aggregates 225,651
acres, more or less, in Imperial and
Riverside Counties, California.
Dated: April 26, 2017.
Ryan K. Zinke,
Secretary of the Interior.
[FR Doc. 2017–08853 Filed 5–1–17; 8:45 am]
BILLING CODE 4310–40–P
notifications disclosing all changes in
membership.
On April 7, 2000, IMS Global filed its
original notification pursuant to Section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on September 13, 2000 (65 FR
55283).
The last notification was filed with
the Department on February 8, 2017. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on March 6, 2017 (82 FR 12639).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
DEPARTMENT OF JUSTICE
[FR Doc. 2017–08850 Filed 5–1–17; 8:45 am]
Antitrust Division
BILLING CODE P
sradovich on DSK3GMQ082PROD with NOTICES
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—IMS Global Learning
Consortium, Inc.
Notice is hereby given that, on April
19, 2017, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), IMS Global Learning
Consortium, Inc. (‘‘IMS Global’’) has
filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Collective Shift/LRNG,
Chicago, IL; Hancom Communication,
Inc., Gyeonggi-do, REPUBLIC OF
KOREA; Harford County Public Schools,
Bel Air, MD; ICT and Systems
˚
˚
Development, Umea University, Umea,
SWEDEN; Infinitas Learning (incl.
Noordhoff Health), Houton, THE
NETHERLANDS; Lee County Public
Schools, Fort Meyers, FL; Mozilla,
Mountain View, CA; Neosho School
District, Neosho, MO; Park Hill School
District, Kansas City, MO; ProExam,
New York, NY; Renaissance Learning,
Wisconsin Rapids, WI; Apereo
Foundation (Sakai/Tsugi), Ann Arbor,
MI; and Trifork Learning Solutions B.V.,
Amsterdam, THE NETHERLANDS, have
been added as parties to this venture.
Also, Newton Public Schools,
Newton, MA; and Lone Star College
Online, The Woodlands, TX, have
withdrawn as parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and IMS Global
intends to file additional written
VerDate Sep<11>2014
16:36 May 01, 2017
Jkt 241001
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Cooperative Research
Group on ROS-Industrial ConsortiumAmericas
Notice is hereby given that, on April
7, 2017, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Southwest Research
Institute—Cooperative Research Group
on ROS-Industrial Consortium-Americas
(‘‘RIC-Americas’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
Membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Magna Services of America
Inc., Troy, MI, and Cognex Corporation,
Natick, MA, have been added as parties
to this venture. In addition, Cessna
Aircraft Company, a Textron Company,
Wichita, KS, has withdrawn as a party
to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open and RIC-Americas
intends to file additional written
notifications disclosing all changes in
membership or planned activities.
On April 30, 2014, RIC-Americas filed
its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on June 9, 2014 (79 FR
32999).
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
The last notification was filed with
the Department on February 21, 2017. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on April 4, 2017 (82 FR 16420).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2017–08852 Filed 5–1–17; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to The National
Cooperative Research and Production
Act of 1993—Medical CBRN Defense
Consortium
Notice is hereby given that, on April
10, 2017, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Medical CBRN
Defense Consortium (‘‘MCDC’’) has filed
written notifications simultaneously
with the Attorney General and the
Federal Trade Commission disclosing
changes in its membership. The
notifications were filed for the purpose
of extending the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances. Specifically,
Codagenix, Inc., Great Neck, NY;
Fraunhofer USA Center for Molecular
Biotechnology, Newark, DE; FUJIFILM
Pharmaceuticals USA, Inc., Boston, MA;
Ibis Biosciences Inc., an Abbott
Company, Carlsbad, CA; Biomeme, Inc.,
Philadelphia, PA; PPD Development LP,
Wilmington, NC; California Institute for
Biomedical Research, La Jolla, CA;
Leidos, Inc., Reston, VA; Merck
Research Laboratories, Whitehouse
Station, NJ; Tetracore, Inc., Rockville,
MD; Mesa Tech International, San
Diego, CA; Synthetic Genomics
Vaccines, Inc., La Jolla, CA; Brimrose
Technology Corporation, Sparks, MD;
Bioo Scientific Corporation, Austin, TX;
Click Diagnostics, Inc., San Jose, CA;
Pulmotect, Inc., Houston, TX; JYANT
Technologies, Inc., Marietta, GA;
YourEncore, Inc., Indianapolis, IN; and
Texas Biomedical Research Institute,
San Antonio, TX, have been added as
parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and MCDC
intends to file additional written
notifications disclosing all changes in
membership.
E:\FR\FM\02MYN1.SGM
02MYN1
Federal Register / Vol. 82, No. 83 / Tuesday, May 2, 2017 / Notices
On November 13, 2015, MCDC filed
its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on January 6, 2016 (81
FR 513).
The last notification was filed with
the Department on February 3, 2017. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on March 7, 2017 (82 FR 12847).
BILLING CODE P
DEPARTMENT OF JUSTICE
BILLING CODE P
DEPARTMENT OF JUSTICE
Executive Office for
Immigration Review, Department of
Justice.
ACTION: 60-day notice.
AGENCY:
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—PXI Systems Alliance,
Inc.
sradovich on DSK3GMQ082PROD with NOTICES
[FR Doc. 2017–08851 Filed 5–1–17; 8:45 am]
Agency Information Collection
Activities; Proposed Collection;
Comments Requested; Notice of Entry
of Appearance as Attorney or
Representative Before the Board of
Immigration Appeals
[FR Doc. 2017–08849 Filed 5–1–17; 8:45 am]
Notice is hereby given that, on April
12, 2017, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), PXI Systems
Alliance, Inc. (‘‘PXI Systems’’) has filed
written notifications simultaneously
with the Attorney General and the
Federal Trade Commission disclosing
changes in its membership. The
notifications were filed for the purpose
of extending the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances. Specifically,
Instrumental Systems Corp., Moscow,
RUSSIA; Sundance Digital Signal
Processing, Inc., Reno, NV; and Circuit
Check, Inc., Maple Grove, MN, have
been added as parties to this venture.
Also, Meilhaus Electric GmbH, Alling,
GERMANY; and Acquisys, Voisins le
Bretonneux, FRANCE, have withdrawn
as parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and PXI Systems
intends to file additional written
notifications disclosing all changes in
membership.
On November 22, 2000, PXI Systems
filed its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on March 8, 2001 (66 FR
13971).
The last notification was filed with
the Department on December 15, 2016.
16:36 May 01, 2017
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[OMB Number 1125–0005]
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
VerDate Sep<11>2014
A notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on January 11, 2017 (82 FR 3360).
Jkt 241001
The Department of Justice
(DOJ), Executive Office for Immigration
Review (EOIR), will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until July
3, 2017.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Jean King, General Counsel, USDOJ–
EOIR–OGC, Suite 2600, 5107 Leesburg
Pike, Falls Church, Virginia 20530;
telephone: (703) 305–0470.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Bureau of Justice
Statistics, including whether the
information will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
SUMMARY:
PO 00000
Frm 00034
Fmt 4703
Sfmt 9990
20489
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection:
1. Type of Information Collection:
Revision and extension of a currently
approved collection.
2. The Title of the Form/Collection:
Notice of Entry of Appearance as
Attorney or Representative Before the
Board of Immigration Appeals.
3. The agency form number: EOIR–27
(OMB #1125–0005).
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Attorneys or representatives
notifying the Board of Immigration
Appeals (Board) that they are
representing a party in proceedings
before the Board.
Other: None.
Abstract: This information collection
is necessary to allow an attorney or
representative to notify the Board that
he or she is representing a party before
the Board.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: It is estimated that 20,669
respondents will complete each form
within approximately 6 minutes.
6. An estimate of the total public
burden (in hours) associated with the
collection: 2,066 annual burden hours.
If additional information is required
contact: Melody D. Braswell,
Department Clearance Officer, United
States Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE., 3E.405B,
Washington, DC 20530.
Dated: April 27, 2017.
Melody D. Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2017–08821 Filed 5–1–17; 8:45 am]
BILLING CODE 4410–30–P
E:\FR\FM\02MYN1.SGM
02MYN1
]]>Agencies
[Federal Register Volume 82, Number 83 (Tuesday, May 2, 2017)]
[Notices]
[Pages 20488-20489]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-08849]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to The National Cooperative Research and
Production Act of 1993--Medical CBRN Defense Consortium
Notice is hereby given that, on April 10, 2017, pursuant to Section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (``the Act''), Medical CBRN Defense Consortium
(``MCDC'') has filed written notifications simultaneously with the
Attorney General and the Federal Trade Commission disclosing changes in
its membership. The notifications were filed for the purpose of
extending the Act's provisions limiting the recovery of antitrust
plaintiffs to actual damages under specified circumstances.
Specifically, Codagenix, Inc., Great Neck, NY; Fraunhofer USA Center
for Molecular Biotechnology, Newark, DE; FUJIFILM Pharmaceuticals USA,
Inc., Boston, MA; Ibis Biosciences Inc., an Abbott Company, Carlsbad,
CA; Biomeme, Inc., Philadelphia, PA; PPD Development LP, Wilmington,
NC; California Institute for Biomedical Research, La Jolla, CA; Leidos,
Inc., Reston, VA; Merck Research Laboratories, Whitehouse Station, NJ;
Tetracore, Inc., Rockville, MD; Mesa Tech International, San Diego, CA;
Synthetic Genomics Vaccines, Inc., La Jolla, CA; Brimrose Technology
Corporation, Sparks, MD; Bioo Scientific Corporation, Austin, TX; Click
Diagnostics, Inc., San Jose, CA; Pulmotect, Inc., Houston, TX; JYANT
Technologies, Inc., Marietta, GA; YourEncore, Inc., Indianapolis, IN;
and Texas Biomedical Research Institute, San Antonio, TX, have been
added as parties to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and MCDC intends to file additional
written notifications disclosing all changes in membership.
[[Page 20489]]
On November 13, 2015, MCDC filed its original notification pursuant
to Section 6(a) of the Act. The Department of Justice published a
notice in the Federal Register pursuant to Section 6(b) of the Act on
January 6, 2016 (81 FR 513).
The last notification was filed with the Department on February 3,
2017. A notice was published in the Federal Register pursuant to
Section 6(b) of the Act on March 7, 2017 (82 FR 12847).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2017-08849 Filed 5-1-17; 8:45 am]
BILLING CODE P
